Robert Langer

Institute Professor and Professor of ChemE & BE

Department
Office of the Institute Professors
Technology Areas
Biotechnology: DNA & RNA Editing, Biomedical Devices & Systems, Cell Separation, Sensors & Monitoring, Biomanufacturing, Tissue Engineering, Prostheses, Synthetic Biology / Chemicals & Materials: Catalysis & Synthesis, Nanotechnology & Nanomaterials, Polymers, Composites / Drug Discovery and Research Tools: Genomics & Proteomics, Cell Interrogation, Cell Lines & Organoids, Cell Culture, Animal Models / Therapeutics: Nucleic Acids, Cell Based Therapy, Regenerative Medicine, Small Molecules, Proteins & Antibodies, Vaccines / Drug Delivery: Microparticles & Nanoparticles, Vectors & Virus like Particles / Biomaterials & Bioelectronics: Health Monitoring, Medical Device Coatings, Tissue Repair / Communication Systems: Wireless / Artificial Intelligence (AI) and Machine Learning (ML) / Sensing & Imaging: Imaging, Chemical & Radiation Sensing / Agriculture & Food: Delivery, Nutrition / Electronics & Photonics: Semiconductors, Quantum Technology, Photonics / Industrial Engineering & Automation: Robotics / Computer Science: Bioinformatics / Energy & Distribution: Electrochemical Devices / Diagnostics: Imaging Agents, Assays

Prolific, award-winning pioneer of new technologies known for revolutionary contributions to the fields of medicine and biotechnology.

Background and Experience

Dr. Langer is one of nine Institute Professors at MIT – the highest honor that can be awarded to a faculty member. He has written more than 1,570 articles and has over 1,400 issued and pending patents worldwide. Dr. Langer’s patents have been licensed or sublicensed to over 400 pharmaceutical, chemical, biotechnology, and medical device companies. He is the most cited engineer in history and was named as one of the 25 most important individuals in biotechnology in the world by Forbes Magazine (1999) and Bio World (1990).

Dr. Langer is one of three living individuals to have received both the United States National Medal of Science (2006) and the United States National Medal of Technology and Innovation (2011). In 1998, he was recognized as “one of history’s most prolific inventors in medicine”, receiving the Lemelson-MIT prize – the world's largest prize for invention. He is the director of the word's largest biomedical engineering lab whose research focuses on the interface of biotechnology and materials science.

Dr. Langer received his Bachelor’s Degree from Cornell University in 1970 and his Sc.D. from the Massachusetts Institute of Technology in 1974, both in Chemical Engineering.

You have to realize that failure is OK. If you want to change the world, you have to be prepared to fail. You put your head down and keep going. ”
Robert Langer

Awards and Honors

Dr. Langer has received over 220 major awards including:

  • 41 honorary doctorates
  • Charles Stark Draper Prize | 2002
  • Albany Medical Center Prize in Medicine and Biomedical Research | 2005
  • Induction into the National Inventors Hall of Fame (2006)
  • Queen Elizabeth Prize for Engineering | 2015
  • Balzan Prize for Biomaterials for Nanomedicine and Tissue Engineering | 2022

Technologies

Drinkable, Tough Hydrogels for Gastrointestinal Applications

Technology / Case number: #24642JQ
Giovanni Traverso / Robert Langer / Gary Liu / Matthew Pickett
Technology Areas: Biotechnology / Chemicals & Materials / Drug Delivery / Therapeutics
Impact Areas: Healthy Living
License

Poly(-amino ester) Microparticles for Micronutrient Fortification

Technology / Case number: #22992
Ana Jaklenec / Robert Langer / Ruiqing Xiao / Linzixuan Rhoda Zhang
Technology Areas: Agriculture & Food / Chemicals & Materials / Drug Delivery
Impact Areas: Healthy Living
License

Altered DNA Repair Pathway Engagement by Engineered CRISPR-Cas9 Nucleases

Technology / Case number: #23588
Vikash Pal Singh Chauhan / Robert Langer / Phillip Sharp
Technology Areas: Biotechnology / Drug Discovery and Research Tools
Impact Areas: Healthy Living
License

Branched Poly(-amino esters) for the Delivery of Nucleic Acids

Technology / Case number: #20333JQ
Giovanni Traverso / Yunhua Shi / Ameya Kirtane / Grace Junyue Zhong / Daniel Reker / Robert Langer / Hyunjoon Kim / Netra Rajesh / James Byrne / Gary Liu
Technology Areas: Biotechnology / Drug Delivery / Therapeutics
Impact Areas: Healthy Living
License

Amino Acid, Peptide, Polypeptide-Lipids (APPL) Derivatives and Uses Thereof

Technology / Case number: #14910Q
Kevin Love / Arturo Vegas / Delai Chen / Yi Chen / Yizhou Dong / Yunlong Zhang / Akinleye Alabi / Robert Langer / Daniel Anderson
Technology Areas: Biotechnology / Therapeutics
Impact Areas: Healthy Living
License

LNP Automation Screening System

Technology / Case number: #26217
Ana Jaklenec / Robert Langer / Linzixuan Rhoda Zhang / Xin Yang / Zhiling Zheng
Technology Areas: Chemicals & Materials / Therapeutics
Impact Areas: Healthy Living
License

Biodegradable Lipid-Like Materials for Applications in siRNA Delivery

Technology / Case number: #15420
Kathryn Whitehead / Arturo Vegas / Yunlong Zhang / Joseph Dorkin / Robert Langer / Daniel Anderson
Technology Areas: Drug Delivery / Therapeutics
Impact Areas: Healthy Living
License

1,3,5-triazinane-2,4,6-trione (TNT) Derivatives and Uses Thereof

Technology / Case number: #15446
Delai Chen / Yizhou Dong / Ahmed Eltoukhy / Joseph Dorkin / Akinleye Alabi / Hao Yin / Robert Langer / Daniel Anderson
Technology Areas: Biotechnology / Therapeutics
Impact Areas: Healthy Living
License

Novel Glucose-Responsive Insulin Formulations Using Chemically Modified Insulin Derivatives and Non-Covalent Insulin-Binding Molecules

Technology / Case number: #15976J
Arturo Vegas / Yair Levi / Yunlong Zhang / Benjamin Tang / Hung-Chieh (Danny) Chou / Kun Xue / Matthew Webber / Rosemary Kanasty / Robert Langer / Daniel Anderson
Technology Areas: Chemicals & Materials / Computer Science / Therapeutics
Impact Areas: Healthy Living
License

Colon Delivery Platform for Constipation Treatment

Technology / Case number: #20570JQ
Giovanni Traverso / Joshua Korzenik / Robert Langer / Christoph Winfried Johannes Steiger
Technology Areas: Therapeutics
Impact Areas: Healthy Living
License

Sign up for technology updates

Sign up now to receive the latest updates on cutting-edge technologies and innovations.